Donate during COVID-19
Treatment options for Advanced Heart Failure (AHF) are increasing in number and complexity and now include devices delivered surgically, through the skin, or as part of hybrid procedures involving both cardiac surgeons and interventional cardiologists.
Currently, interventional cardiology training does not include training in AHF. For the majority of interventional cardiologists, AHF training is not required. However, for a growing number of interventional cardiologists, an additional year of in-depth training in Advanced Heart Failure and Transplant Cardiology (AHFTC) will provide the knowledge to make optimal decisions for patients with AHF who are being considered for drug or device therapy, and to be dual board eligible.
The group of interventional heart failure specialists will be uniquely positioned to evaluate and implement emerging drug- and device-based therapies for the management of all subtypes of heart failure, including: heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), valvular heart failure, right ventricular failure, pulmonary hypertension, cardiorenal syndrome, acute decompensated HF, cardiogenic shock and complication associated with left ventricular assist devices.
We are currently recruiting for the IHF Class of 2021, which involves Advanced Heart Failure and Transplant Cardiology Training in 2021 followed by Interventional Cardiology Training in 2022.
View all of our cardiovascular training opportunities >
An unprecedented gift to the newly-formed CVCRI from Boston-based Abiomed, Inc. will resource this novel fellowship program. Under the direction of Dr. Navin Kapur, The Robert Kung Interventional Heart Failure Clinical and Research Fellowship Program grant will be used to support the annual salaries and related costs of dual fellows in IHF:
This partnership represents an innovative and integrated way for Tufts MC to provide scientific, educational and training opportunities to ambitious and talented Advanced Heart Failure students and can be used as a model for further collaboration between research, industry, and philanthropy across the Medical Center.
Learn more about the Fellowship >
The primary objective of the Interventional Heart Failure Training is to develop interventional cardiologists with an advanced understanding of heart failure physiology, diagnosis and management with further in-depth technical training related to device implementation for patients with advanced heart failure.
Navin K. Kapur, MD
David DeNofrio, MD
Michael S. Kiernan, MD, MSc
Carey D. Kimmelstiel, MD
Amanda Vest, MBBS, MPH
Andrew R. Weintraub, MD
Eligibility: We are currently recruiting for the IHF Class of 2021 (HF 2021 and IC 2022). To be eligible, applicants must have completed 3 years in an ACGME certified Cardiology Training Program in the United States by June 2021.
Requirements: Cardiology fellows who enter the Interventional Heart Failure Training are expected to complete one full year of Accreditation Council for Graduate Medical Education (ACGME) certified Advanced Heart Failure and Transplant Cardiology Training followed by one full year of ACGME certified Interventional Cardiology Training (see table below). Graduates of the program will be dual eligible in Advanced Heart Failure and Transplant Cardiology and Interventional Cardiology.
Applications should be submitted to Rebecca Thorne at 617-636-4769 or email@example.com
Acute Cardiac Unloading and Recovery (A-CURE)
Treatment of Cardiogenic Shock: Heart Team Approach
Navin K. Kapur, MD, Interventional Cardiology & Advanced Heart Failure; Executive Director, Cardiovascular Center for Research and Innovation (CVCRI); Director, Acute Circulatory Support Program; Director, Interventional Research Laboratories
Division of Cardiology
Tufts Medical Center
800 Washington Street, Box 80
Boston, MA 02111